市場調査レポート

Dダイマーの世界市場 2014〜2022年 (検査方法別:ポイントオブケア検査、ラボ検査、用途別:深部静脈血栓症、肺塞栓、播種性血管内凝固症候群) - 業界分析、規模、シェア、成長、動向および予測

D-dimer Testing Market (Testing Methods: Point-of-Care Tests, Laboratory Tests and Applications) - Global Industry Analysis, Size, Share, Volume, Growth, Trends and Forecast 2014 - 2022

発行 Transparency Market Research 商品コード 332673
出版日 ページ情報 英文 129 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
Dダイマーの世界市場 2014〜2022年 (検査方法別:ポイントオブケア検査、ラボ検査、用途別:深部静脈血栓症、肺塞栓、播種性血管内凝固症候群) - 業界分析、規模、シェア、成長、動向および予測 D-dimer Testing Market (Testing Methods: Point-of-Care Tests, Laboratory Tests and Applications) - Global Industry Analysis, Size, Share, Volume, Growth, Trends and Forecast 2014 - 2022
出版日: 2015年05月25日 ページ情報: 英文 129 Pages
概要

現在、体外診断市場は世界的に最も急速に成長する市場のひとつです。診断試験所は、高品質で効率的な検査ソリューションを提供するという課題に直面しています。処理時間の短縮と信頼性の高い検査結果を実現したポイントオブケア検査が勢いを増しています。こうした中、深部静脈血栓症や肺塞栓、播種性血管内凝固症候群の除外を確認するためにDダイマーアッセイおよびPOCキットが開発されました。

当レポートは、世界のDダイマー市場について調査し、検査方法別、用途別、地域別の動向、2012〜2022年の市場成長予測、および市場に参入する企業のプロファイルをまとめています。

第1章 序論

第2章 エグゼクティブサマリー

第3章 市場概要

  • イントロダクション
  • 市場動向
    • 市場促進因子
      • 凝固検査を必要とする患者数の増加と、より自動装置へのより感度の高い特定の止血マーカーの導入
      • VTE患者の抗凝固治療のモニタリングに役立てられることが市場を促進
    • 市場阻害因子
      • D-二量体価の解釈が大きな課題
      • POCによるDダイマーの臨床における受入が障壁
    • 市場の機会
      • バイオインフォマティクスと統合ソフトウェアへの注力
      • ED手術改善のための即時診断検査導入の機会拡大
  • ポーターズファイブフォース分析
  • 市場の魅力度分析
  • 競合環境
  • バリューチェーン分析

第4章 検査方法別市場

  • イントロダクション
  • ポイントオブケア検査
  • ラボ検査

第5章 用途別市場

  • イントロダクション
  • 深部静脈血栓症
  • 肺塞栓
  • 播種性血管内凝固症候群

第6章 地域別市場

  • 概要
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・北アフリカ
  • その他の諸国

第7章 提言

第8章 企業プロファイル

  • Abbott Laboratories, Inc.
  • Alere, Inc.
  • Beckman Coulter, Inc.
  • Bio/Data Corporation
  • Becton, Dickinson and Company
  • Corgenix Medical Corporation
  • F. Hoffmann-La Roche Ltd.
  • Helena Biosciences
  • Sysmex Corporation
  • Siemens Healthcare
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech plc

図表

目次

Title: D-dimer Testing Market (Testing Methods: Point-of-Care Tests and Laboratory Tests; Applications: Deep Vein Thrombosis, pulmonary Embolism and Disseminated Intravascular Coagulation) - Global Industry Analysis, Size, Share, Volume, Growth, Trends and Forecast 2014 - 2022.

At present, the in vitro diagnostics market is one of the fastest growing markets globally. This remarkable growth can be attributed to the improved health care awareness, preference of the people for preventive health checkups, accessibility to disease specific tests, and shift from manual to semi-automated and automated instruments. Diagnostic laboratories are facing challenges in delivering high-quality, efficient and timely testing solutions due to rising health care awareness and stringent regulations that put pressure on the health care budgets. This has led to growing adoption of automated solutions and new analyzers that deliver high throughput in lesser time and with enhanced efficiency. Point-of care testing has gained momentum in the past few years to meet the demand for quick turnaround time, thus accelerating reliable results. D-dimer assays and POC kits have been developed to confirm the exclusion of deep vein thrombosis (DVT), pulmonary embolism (PE), and disseminated intravascular coagulation (DIC).

The D-dimer testing market has been extensively analyzed on the basis of testing methods, applications, and geography. Testing methods include point-of-care testing (POC) and laboratory testing. Laboratory testing has been further segmented into coagulation analyzers and clinical chemistry analyzers. Applications comprise deep vein thrombosis (DVT), pulmonary embolism (PE), and disseminated intravascular coagulation (DIC). Each of the segments has been analyzed in detail for market trends, number of D-dimer tests, recent developments, outlook, and opportunities. The report provides current and future market size for each segment and sub-segment for the period from 2014 to 2022, in terms of revenue in USD million and number of tests in million, considering 2012 and 2013 as the base years. The compound annual growth rate (%CAGR) for each market segment has been provided for the forecast period from 2014 to 2022 along with the estimations of market size.

Geographically, the global D-dimer testing market has been classified into six major geographical regions: North America (U.S., Canada), Europe (Germany, U.K.), Asia-Pacific (Japan, China), Latin America (Brazil, Mexico), MENA (Saudi Arabia, U.A.E.), and Rest of the World (RoW). The regions have been further segmented by major countries. The current and future market sizes in terms of revenue (USD million) and number of tests (million) of these regional markets and their major countries have been provided in the report for the period from 2012 to 2022, with their growth rate (%) for the period from 2014 to 2022. The study also offers a list of recommendations and highlights of the market for new companies willing to enter the market and for existing companies to increase market shares, which is likely to help in the decision-making process. Heat map analysis has also been provided for various hematology and automated analyzer manufacturers designed to perform D-dimer tests.

The market overview section of the report demonstrates the market dynamics and market trends such as drivers, restraints, and opportunities that influence the current and future status of the D-dimer industry. The report also covers market attractiveness analysis, Porter's Five Forces analysis and key market share analysis in the market overview section, in order to give a thorough analysis of the overall competitive scenario in the global D-dimer testing market.

The report concludes with the company profiles section that includes key information about the major players in the market. Key players profiled in this report include Abbott Laboratories, Alere, Inc., Beckman Coulter, Inc., Bio/Data Corporation, Becton, Dickinson and Company, Corgenix, F. Hoffman-La Roche Ltd., Helena Biosciences, Siemens Healthcare, Sysmex Corporation, Thermo Fisher Scientific, and Trinity Biotech. Each of these players is profiled in the report considering parameters such as company overview, financial overview, business strategies, product portfolio, and recent developments.

The global D-dimer Testing Market is segmented as follows:

  • D-dimer Testing Market Revenue (USD Million) and Volume (Number of Tests), by Testing Method
    • Point-of-Care Tests
    • Laboratory Tests
      • Coagulation Analyzers
      • Clinical Chemistry Analyzers
  • D-dimer Testing Market Revenue (USD Million) and Volume (Number of Tests), by Applications
    • Deep Vein Thrombosis
    • Pulmonary Embolism
    • Disseminated Intravascular Coagulation
  • D-dimer Testing Market Revenue (USD Million) and Volume (Number of Tests), by Geography
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • Rest of Europe
    • Asia Pacific
      • Japan
      • China
      • Rest of Asia Pacific
    • Latin America (LATAM)
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East and North Africa (MENA)
      • Saudi Arabia
      • United Arab Emirates (U.A.E)
      • Rest of MENA
    • Rest of the World (RoW)

Table of Contents

Chapter 1 - Preface

  • 1.1. Report Description
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Secondary Research
    • 1.3.2. Primary Research
  • 1.4. Assumptions
  • 1.5. List of Abbreviations

Chapter 2 - Executive Summary

  • 2.1 Market Snapshot: Global D-dimer Testing Market (2013 & 2022)
  • 2.2 Global D-dimer Testing Market Volume, by Geography, 2012 - 2022 (No. of Tests in Millions)
  • 2.3 Comparative Analysis: Global D-dimer Testing Market Revenue, by Geography, 2013 & 2022 (Value %)

Chapter 3 - D-dimer Testing Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers
      • 3.2.1.1. Increasing number of patients necessitating coagulation testing as well as introduction of more sensitive and specific markers of hemostasis on automated instruments
      • 3.2.1.2. Assistance in monitoring anti-coagulation therapy in patients with VTE to drive the market
    • 3.2.2. Market Restraints
      • 3.2.2.1. Interpretation of D-dimer values is a major challenge
      • 3.2.2.2. Clinical acceptance of POC D-dimer testing remains an obstacle
    • 3.2.3. Market Opportunities
      • 3.2.3.1. Focus on bioinformatics and integrated software
      • 3.2.3.2. Increasing opportunities to implement rapid diagnostic testing to improve ED operations
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining power of suppliers
    • 3.3.2. Bargaining power of buyers
    • 3.3.3. Threat of substitutes
    • 3.3.4. Threat of new entrants
    • 3.3.5. Competitive rivalry
  • 3.4. Market Attractiveness Analysis: Global D-dimer Testing Market, by Geography
  • 3.5. Competitive Landscape
    • 3.5.1. Market Share Analysis: Global D-dimer Testing Market
      • 3.5.1.1. Methodology
      • 3.5.1.2. Analysis
        • 3.5.1.2.1 Market Share Analysis: Global D-dimer Testing Market, 2013 (Value %)
    • 3.5.2 Heat Map Analysis: Global D-dimer Testing Market
      • 3.5.2.1 Methodology
      • 3.5.2.2 Analysis
        • 3.5.2.2.1 Heat Map Analysis for the Global D-dimer Testing Market, by Key Players, 2013
  • 3.6 Value Chain Analysis
    • 3.6.1 Value Chain Analysis: Global D-dimer Testing Market

Chapter 4 - Global D-dimer Testing Market Revenue (USD Million) and No. of Tests (Million), by Testing Method, 2012 - 2022

  • 4.1 Introduction
    • 4.1.1 Global D-dimer Market Revenue, by Testing Method, 2012 -2022 (USD Million)
    • 4.1.2 Global D-dimer Market Volume, by Testing Method, 2012 -2022 (No. of Tests in Millions)
    • 4.1.3 Comparative Analysis: Global D-dimer Testing Market Revenue, by Testing Methods, 2013 & 2022 (Value %)
  • 4.2 Point-of-care Testing
    • 4.2.1 Global D-dimer Market Revenue, by Point-of-Care Test, 2012 - 2022 (USD Million)
    • 4.2.2 Global D-dimer Market Volume, by Point-of-Care Test, 2012 - 2022 (No. of Tests in Millions)
  • 4.3 Laboratory Testing
    • 4.3.1 Global D-dimer Market Revenue, by Laboratory test, 2012 - 2022 (USD Million)
    • 4.3.2 Global D-dimer Market Volume, by Laboratory test, 2012 - 2022 (No. of Tests in Millions)
    • 4.3.3 Coagulation Analyzers
      • 4.3.3.1 Global D-dimer Market Revenue, by Coagulation Analyzers, 2012 - 2022 (USD Million)
    • 4.3.4 Clinical Chemistry Analyzers
      • 4.3.4.1 Global D-dimer Market Revenue, by Clinical Chemistry Analyzers, 2012 - 2022 (USD Million)

Chapter 5 - Global D-dimer Testing Market Revenue (USD Million) and Volume (No. of Tests in Millions), by Application, 2012 - 2022

  • 5.1 Introduction
    • 5.1.1 Global D-dimer Market Revenue, by Application, 2012 - 2022 (USD Million)
    • 5.1.2 Global D-dimer Market Volume, by Application, 2012 - 2022 (No. of Tests in Millions)
    • 5.1.3 Comparative Analysis: Global D-dimer Testing Market Revenue, by Application, 2013 & 2022 (Value %)
  • 5.2 Deep Vein Thrombosis (DVT)
    • 5.2.1 Global Deep Vein Thrombosis Market Revenue, 2012 - 2022 (USD Million)
    • 5.2.2 Global Deep Vein Thrombosis Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • 5.3 Pulmonary Embolism (PE)
    • 5.3.1 Global Pulmonary Embolism Market Revenue, 2012 - 2022 (USD Million)
    • 5.3.2 Global Pulmonary Embolism Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • 5.4 Disseminated Intravascular Coagulation (DIC)
    • 5.4.1 Global Disseminated Intravascular Coagulation Market Revenue, 2012 - 2022 (USD Million)
    • 5.4.2 Global Disseminated Intravascular Coagulation Market Volume, 2012 - 2022 (No. of Tests in Millions)

Chapter 6 - Global D-dimer Testing Market Revenue (USD Million) & Volume (No. of Tests in Millions), by Geography, 2012 - 2022

  • 6.1 Overview
    • 6.1.1 Global D-dimer Testing Market Revenue, by Geography, 2012 - 2022 (USD Million)
    • 6.1.2 Global D-dimer Testing Market Volume, by Geography, 2012 - 2022 (No. of Tests in Millions)
  • 6.2 North America
    • 6.2.1 North America D-dimer Market Revenue, by Country, 2012 - 2022 (USD Million)
    • 6.2.2 North America D-dimer Testing Market Volume, 2012 - 2022, (No. of Tests in Millions)
    • 6.2.3 United States
      • 6.2.3.1 U.S. D-dimer Market Revenue, 2012 - 2022 (USD Million)
      • 6.2.3.2 U.S. D-dimer Market Volume, 2012 - 2022 (No. of Tests in Millions)
    • 6.2.4 Canada
      • 6.2.4.1 Canada D-dimer Market Revenue, 2012 - 2022 (USD Million)
      • 6.2.4.2 Canada D-dimer Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • 6.3 Europe
    • 6.3.1 Europe D-dimer Market Revenue, by Country, 2012 - 2022 (USD Million)
    • 6.3.2 Europe D-dimer Testing Market Volume, 2012 - 2022 (No. of Tests in Millions)
    • 6.3.3 Germany
      • 6.3.3.1 Germany D-dimer Market Revenue, 2012 - 2022 (USD Million)
      • 6.3.3.2 Germany D-dimer Market Volume, 2012 - 2022 (No. of Tests in Millions)
    • 6.3.4 United Kingdom
      • 6.3.4.1 United Kingdom D-dimer Market Revenue, 2012 - 2022 (USD Million)
      • 6.3.4.2 United Kingdom D-dimer Market Volume, 2012 - 2022 (No. of Tests in Millions)
    • 6.3.5 Rest of Europe
      • 6.3.5.1 Rest of Europe D-dimer Market Revenue, 2012 - 2022 (USD Million)
      • 6.3.5.2 Rest of Europe D-dimer Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • 6.4 Asia Pacific
    • 6.4.1 Asia Pacific D-dimer Market Revenue, by Country, 2012 - 2022 (USD Million)
    • 6.4.2 Asia Pacific D-dimer Testing Market Volume, 2012 - 2022 (No. of Tests in Millions)
    • 6.4.3 Japan
      • 6.4.3.1 Japan D-dimer Market Revenue, 2012 - 2022 (USD Million)
      • 6.4.3.2 Japan D-dimer Market Volume, 2012 - 2022 (No. of Tests in Millions)
    • 6.4.4 China
      • 6.4.4.1 China D-dimer Market Revenue, 2012 - 2022 (USD Million)
      • 6.4.4.2 China D-dimer Market Volume, 2012 - 2022 (No. of Tests in Millions)
    • 6.4.5 Rest of Asia Pacific
      • 6.4.5.1 Rest of Asia Pacific D-dimer Market Revenue, 2012 - 2022 (USD Million)
      • 6.4.5.2 Rest of Asia Pacific D-dimer Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • 6.5 Latin America (LATAM)
    • 6.5.1 Latin America D-dimer Market Revenue, by Country, 2012 - 2022 (USD Million)
    • 6.5.2 LATAM D-dimer Testing Market Volume, 2012 - 2022 (No. of Tests in Millions)
    • 6.5.3 Brazil
      • 6.5.3.1 Brazil D-dimer Market Revenue, 2012 - 2022 (USD Million)
      • 6.5.3.2 Brazil D-dimer Market Volume, 2012 - 2022 (No. of Tests in Millions)
    • 6.5.4 Mexico
      • 6.5.4.1 Mexico D-dimer Market Revenue, 2012 - 2022 (USD Million)
      • 6.5.4.2 Mexico D-dimer Market Volume, 2012 - 2022 (No. of Tests in Millions)
    • 6.5.5 Rest of LATAM
      • 6.5.5.1 Rest of LATAM D-dimer Market Revenue, 2012 - 2022 (USD Million)
      • 6.5.5.2 Rest of LATAM D-dimer Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • 6.6 Middle East and North Africa (MENA)
    • 6.6.1 Middle East and North Africa D-dimer Market Revenue, by Country, 2012 - 2022 (USD Million)
    • 6.6.2 MENA D-dimer Testing Market Volume, 2012 - 2022 (No. of Tests in Millions)
    • 6.6.3 Saudi Arabia
      • 6.6.3.1 Saudi Arabia D-dimer Market Revenue, 2012 - 2022 (USD Million)
      • 6.6.3.2 Saudi Arabia D-dimer Market Volume, 2012 - 2022 (No. of Tests in Millions)
    • 6.6.4 United Arab Emirates
      • 6.6.4.1 United Arab Emirates D-dimer Market Revenue, 2012 - 2022 (USD Million)
      • 6.6.4.2 United Arab Emirates D-dimer Market Volume, 2012 - 2022 (No. of Tests in Millions)
    • 6.6.5 Rest of Middle East and North Africa
      • 6.6.5.1 Rest of Middle East and North Africa D-dimer Market Revenue, 2012 - 2022 (USD Million)
      • 6.6.5.2 Rest of Middle East and North Africa Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • 6.7 Rest of the World (RoW)
    • 6.7.1 Rest of the World D-dimer Market Revenue, 2012 - 2022 (USD Million)
    • 6.7.2 Rest of the World D-dimer Testing Market Volume, 2012 - 2022 (No. of Tests in Millions)

Chapter 7 - Recommendations

  • 7.1. Focus on technological advancements and development of POC settings
  • 7.2. Designing of new methods to adjust the value of D-Dimer test according to the patients age
  • 7.3. Organizing product awareness programs
  • 7.4. Investing in emerging economies

Chapter 8 - Company Profiles

  • 8.1. Abbott Laboratories, Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Financial Overview
    • 8.1.3. Product Portfolio
    • 8.1.4. Business Strategies
    • 8.1.5. Recent Developments
  • 8.2. Alere, Inc.
    • 8.2.1. Company Overview
    • 8.2.2. Financial Overview
    • 8.2.3. Product Portfolio
    • 8.2.4. Business Strategies
    • 8.2.5. Recent Developments
  • 8.3. Beckman Coulter, Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Financial Overview
    • 8.3.3. Product Portfolio
    • 8.3.4. Business Strategies
    • 8.3.5. Recent Developments
  • 8.4. Bio/Data Corporation
    • 8.4.1. Company Overview
    • 8.4.2. Financial Overview
    • 8.4.3. Product Portfolio
    • 8.4.4. Business Strategies
    • 8.4.5. Recent Developments
  • 8.5. Becton, Dickinson and Company
    • 8.5.1. Company Overview
    • 8.5.2. Financial Overview
    • 8.5.3. Product Portfolio
    • 8.5.4. Business Strategies
    • 8.5.5. Recent Developments
  • 8.6. Corgenix Medical Corporation
    • 8.6.1. Company Overview
    • 8.6.2. Financial Overview
    • 8.6.3. Product portfolio
    • 8.6.4. Business Strategies
    • 8.6.5. Recent Developments
  • 8.7. F. Hoffmann-La Roche Ltd.
    • 8.7.1. Company Overview
    • 8.7.2. Financial Overview
    • 8.7.3. Product portfolio
    • 8.7.4. Business Strategies
    • 8.7.5. Recent Developments
  • 8.8. Helena Biosciences
    • 8.8.1. Company Overview
    • 8.8.2. Financial Overview
    • 8.8.3. Product portfolio
    • 8.8.4. Business Strategies
    • 8.8.5. Recent Developments
  • 8.9. Sysmex Corporation
    • 8.9.1. Company Overview
    • 8.9.2. Financial Overview
    • 8.9.3. Product portfolio
    • 8.9.4. Business Strategies
    • 8.9.5. Recent Developments
  • 8.10. Siemens Healthcare
    • 8.10.1. Company Overview
    • 8.10.2. Financial Overview
    • 8.10.3. Product Portfolio
    • 8.10.4. Business Strategies
    • 8.10.5. Recent Developments
  • 8.11. Thermo Fisher Scientific, Inc.
    • 8.11.1. Company Overview
    • 8.11.2. Financial Overview
    • 8.11.3. Product portfolio
    • 8.11.4. Business Strategies
    • 8.11.5. Recent Developments
  • 8.12. Trinity Biotech plc
    • 8.12.1. Company Overview
    • 8.12.2. Financial Overview
    • 8.12.3. Product portfolio
    • 8.12.4. Business Strategies
    • 8.12.5. Recent Developments

List of Figures

  • FIG. 1: Global D-dimer Testing Market Segmentation
  • FIG. 2: Global D-dimer Testing Market Volume, by Geography, 2012 - 2022 (No. of Tests in Million)
  • FIG. 3: Comparative Analysis: Global D-dimer Testing Market Revenue, by Geography, 2013 & 2022E (Value %)
  • FIG. 4: Porter's Five Forces Analysis: Global D-dimer Testing Market
  • FIG. 5: Market Attractiveness Analysis: Global D-dimer Testing Market, by Geography
  • FIG. 6: Market Share Analysis: Global D-dimer Testing Market, 2013 (Value %)
  • FIG. 7: Heat Map Analysis: Global D-Dimer Testing Market, by Key Players
  • FIG. 8: Value Chain Analysis: Global D-dimer Testing Market
  • FIG. 9: Comparative Analysis: Global D-dimer Testing Market Revenue, by Testing Methods, 2013 & 2022 (Value %)
  • FIG. 10: Global D-dimer Market Revenue, by Point-of-Care Test, 2012 - 2022 (USD Million)
  • FIG. 11: Global D-dimer Market Volume, by Point-of-Care Test, 2012 - 2022 (No. of Tests in Millions)
  • FIG. 12: Global D-dimer Market Revenue, by Coagulation Analyzers, 2012 - 2022 (USD Million)
  • FIG. 13: Global D-dimer Market Revenue, by Clinical Chemistry Analyzers, 2012 - 2022 (USD Million)
  • FIG. 14: Comparative Analysis: Global D-dimer Testing Market Revenue, by Application, 2013 & 2022 (Value %)
  • FIG. 15: Global Deep Vein Thrombosis Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 16: Global Deep Vein Thrombosis Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • FIG. 17: Global Pulmonary Embolism Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 18: Global Pulmonary Embolism Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • FIG. 19: Global Disseminated Intravascular Coagulation Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 20: Global Disseminated Intravascular Coagulation Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • FIG. 21: North America D-dimer Testing Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • FIG. 22: U.S. D-dimer Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 23: U.S. D-dimer Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • FIG. 24: Canada D-dimer Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 25: Canada D-dimer Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • FIG. 26: Europe D-dimer Testing Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • FIG. 27: Germany D-dimer Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 28: Germany D-dimer Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • FIG. 29: United Kingdom D-dimer Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 30: United Kingdom D-dimer Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • FIG. 31: Rest of Europe D-dimer Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 32: Rest of Europe D-dimer Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • FIG. 33: Asia Pacific D-dimer Testing Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • FIG. 34: Japan D-dimer Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 35: Japan D-dimer Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • FIG. 36: China D-dimer Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 37: China D-dimer Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • FIG. 38: Rest of Asia Pacific D-dimer Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 39: Rest of Asia Pacific D-dimer Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • FIG. 40: LATAM D-dimer Testing Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • FIG. 41: Brazil D-dimer Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 42: Brazil D-dimer Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • FIG. 43: Mexico D-dimer Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 44: Mexico D-dimer Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • FIG. 45: Rest of LATAM D-dimer Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 46: Rest of LATAM D-dimer Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • FIG. 47: MENA D-dimer Testing Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • FIG. 48: Saudi Arabia D-dimer Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 49: Saudi Arabia D-dimer Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • FIG. 50: United Arab Emirates D-dimer Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 51: United Arab Emirates D-dimer Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • FIG. 52: Rest of Middle East and North Africa D-dimer Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 53: Rest of Middle East and North Africa D-dimer Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • FIG. 54: Rest of the World D-dimer Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 55: Rest of the World D-dimer Testing Market Volume, 2012 - 2022 (No. of Tests in Millions)
  • FIG. 56: Abbott Laboratories, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 57: Alere, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 58: Becton, Dickinson and Company: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 59: Corgenix Medical Corp.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 60: F. Hoffmann-La Roche Ltd.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 61: Sysmex Corporation: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 62: Siemens Healthcare: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 63: Thermo Fisher Scientific, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 64: Trinity Biotech plc : Annual Revenue, 2011 - 2013 (USD Million)

List of Tables

  • TABLE 1 : ist of Abbreviations
  • TABLE 2 : arket Snapshot: Global D-dimer Testing Market (2013 & 2022)
  • TABLE 3 : revalence of Venous Thromboembolism
  • TABLE 4 : lobal D-dimer Market Revenue, by Testing Method, 2012 - 2022 (USD Million)
  • TABLE 5 : lobal D-dimer Market Volume, by Testing Method, 2012 - 2022 (No. of Tests in Millions)
  • TABLE 6 : lobal D-dimer Market Revenue, by Application, 2012 - 2022 (USD Million)
  • TABLE 7 : lobal D-dimer Market Volume, by Application, 2012 - 2022 (No. of Tests in Millions)
  • TABLE 8 : lobal D-dimer Testing Market Revenue, by Geography, 2012 - 2022 (USD Million)
  • TABLE 9 : lobal D-dimer Testing Market Volume, by Geography, 2012 - 2022 (No. of Tests in Millions)
  • TABLE 10 : orth America D-dimer Market Revenue, by Country, 2012 - 2022 (USD Million)
  • TABLE 11 : urope D-dimer Market Revenue, by Country, 2012 - 2022 (USD Million)
  • TABLE 12 : sia Pacific D-dimer Market Revenue, by Country, 2012 - 2022 (USD Million)
  • TABLE 13 : atin America D-dimer Market Revenue, by Country, 2012 - 2022 (USD Million)
  • TABLE 14 : iddle East and North Africa D-dimer Market Revenue, by Country, 2012 - 2022 (USD Million)
Back to Top